Jarlath Keating Joins as President of Solvias Group USA
Press Release: Solvias Expands U.S. Capabilities as RTP Center Becomes cGMP-Ready
Article: CSO Danny Galbraith, PhD shares his insights with Drug Target Review.
Webinar: Antibody Drug Conjugates Overcoming Analytical Challenges in Next Gen Cancer Therapies 22
Solvias Earns Strong First Assessment from EcoVadis
Center of Excellence for Biologics and Cell & Gene Therapy opens in Research Triangle Park (RTP), North Carolina.
Deep CMC testing expertise across
the pharmaceutical spectrum
One partner for your entire
drug development journey
Let’s advance your development project
175
+
PhD-level scientists
800
+
team members in Europe & U.S.
700
+
customers worldwide
19
of the top 20 pharma companies choose Solvias
